Survival Interpretation
Prognosis
Patient Comparison Table
Add, edit, or delete patient scenarios. All variables from main calculator included.
“Gastro” is presented as a predictive tool that engages users through its interactive features, thereby improving the understanding of gastric cancer survival statistics. Future development will focus on incorporating additional variables to enrich the tool’s predictive capabilities.
This work was supported by the National Cancer Center Grant (NCC 24H1100-1). In addition, one of the authors, Anujin Rentsentavkhai was supported by the “International Cooperation & Education Program” (NCCRI·NCCI 52210-52211, 2024)” of National Cancer Center, Korea.
Add, edit, or delete patient scenarios. All variables from main calculator included.
Data were obtained from the Cancer Public Library Database (CPLD), established under the Korean Clinical Data Utilization Network for Research Excellence (K-CURE) project. The CPLD integrates four nationwide population-based databases:
The database encompasses 96.7% of all cancer incidence cases in Korea, with an estimated completeness of 98.3% (as of 2020).
Primary stomach cancer patients diagnosed between 2012 and 2020 were identified from the CPLD (initial pool: n = 248,501). The following exclusion criteria were applied:
The final analytic cohort comprised 180,462 patients diagnosed between 2014 and 2020, with follow-up through December 31, 2021 (maximum follow-up: ~8 years).
| Variable | Categories / Range |
|---|---|
| Age at diagnosis | Continuous, 30–85 years |
| Sex | Male / Female |
| SEER Stage | Localized / Regional / Distant / Unknown |
| Tumor Location | Upper / Middle / Lower / Overlapped / Unknown |
| Comorbidity | None / Mild / Moderate / Severe
Based on 13 conditions (Charlson Comorbidity Index adapted for gastric cancer): myocardial infarction, congestive heart failure, cerebrovascular disease, dementia, diabetes, liver disease, paraplegia, chronic pulmonary disease, renal disease, rheumatologic disease, peptic ulcer disease, peripheral vascular disease, mild/severe liver disease. Weights were derived from Cox regression on other-cause mortality in this cohort. |
| Variable | Categories |
|---|---|
| BMI | Underweight (<20) / Normal (20–24) / Pre-obese (25–29) / Obese (≥30) |
| Metabolic Syndrome | Yes / No
Defined as ≥3 of: abdominal obesity, high blood pressure, elevated triglycerides, low HDL, elevated fasting glucose. |
| Smoking | Never / Ex-smoker / Current smoker |
| Drinking | Non-drinker / Low-risk / High-risk
Classified by daily alcohol intake (sex-specific WHO thresholds). |
| Physical Activity | None / Low / High
Based on weekly MET-minutes (IPAQ protocol). |
| Variable | Categories |
|---|---|
| Initial Surgery | Endoscopic / Subtotal Gastrectomy / Total Gastrectomy / Others / None |
| Chemotherapy | Yes / No |
| Radiotherapy | Yes / No |
All-cause mortality is modelled using the Cox proportional hazards model. Every patient who remains alive at end of follow-up is censored.
$$S(t\mid x) = e^{-H_0(t)\, e^{\beta x}}$$where $H_0(t)$ is the baseline cumulative hazard and $\beta x$ is the linear predictor.
A second Cox model is fitted with gastric cancer death (GCD) as the sole event; deaths from other causes are censored alongside survivors. This isolates the hazard attributable to gastric cancer under the assumption of independent competing risks.
$$\lambda_{cs}(t) = \lim_{\Delta t \to 0} \frac{P(t \le T < t+\Delta t,\; D=\text{GCD} \mid T \ge t)}{\Delta t}$$The cumulative incidence of each cause of death is estimated via the Fine-Gray model, which keeps patients who experienced a competing event in the risk set. The outcome variable (crisk) is coded as:
Separate models are fitted for GCD (failcode = 1) and OCD (failcode = 2).
$$\lambda_{sd}(t) = \lim_{\Delta t \to 0} \frac{P(t \le T < t+\Delta t,\; D=k \mid T \ge t \text{ or } (T < t \text{ and } D \ne k))}{\Delta t}$$ $$F_k(t\mid x) = 1 - e^{-\Lambda_{sd,k}(t)\, e^{\gamma_k x}}$$Restricted Mean Survival Time (RMST) — expected survival time up to horizon $\tau$:
$$\text{RMST}(\tau) = \int_0^{\tau} S(t)\, dt$$Conditional Survival (CS) — probability of surviving an additional $t$ years given survival to landmark time $\tau$:
$$CS(t \mid \tau) = \frac{S(\tau + t)}{S(\tau)}$$